These data suggest that curcumin synergizes with cisplatin to inhibit the proliferation, glutamine metabolism and drug resistance of colon cancer cells by targeting the miR-137-glutaminase axis [63]. The gene discussed is GLS; the disease is malignant colon neoplasm.